{
  "id": [
    "32698772"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "32698772"
  ],
  "pmcid": [
    "PMC7374822"
  ],
  "fullTextIdList": [
    {
      "fullTextId": [
        "PMC7374822"
      ]
    }
  ],
  "doi": [
    "10.1186/s12879-020-05255-5"
  ],
  "title": [
    "Importance of early identification of PrEP breakthrough infections in a generalized HIV epidemic: a case report from a PrEP demonstration project in South Africa."
  ],
  "authorString": [
    "Naicker CL, Mansoor LE, Dawood H, Naidoo K, Singo D, Matten D, Williamson C, Abdool Karim Q."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Naicker CL"
          ],
          "firstName": [
            "Cherise L"
          ],
          "lastName": [
            "Naicker"
          ],
          "initials": [
            "CL"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Mansoor LE"
          ],
          "firstName": [
            "Leila E"
          ],
          "lastName": [
            "Mansoor"
          ],
          "initials": [
            "LE"
          ],
          "authorId": [
            {
              "_": "0000-0002-7607-348X",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa. leila.mansoor@caprisa.org."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Dawood H"
          ],
          "firstName": [
            "Halima"
          ],
          "lastName": [
            "Dawood"
          ],
          "initials": [
            "H"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Naidoo K"
          ],
          "firstName": [
            "Kogieleum"
          ],
          "lastName": [
            "Naidoo"
          ],
          "initials": [
            "K"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.",
                "MRC-CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, University of KwaZulu-Natal, Durban, South Africa."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Singo D"
          ],
          "firstName": [
            "Denzhe"
          ],
          "lastName": [
            "Singo"
          ],
          "initials": [
            "D"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Division of Medical Virology, University of Cape Town, Cape Town, South Africa.",
                "The National Health Laboratory Service, Cape Town, South Africa."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Matten D"
          ],
          "firstName": [
            "David"
          ],
          "lastName": [
            "Matten"
          ],
          "initials": [
            "D"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Division of Medical Virology, University of Cape Town, Cape Town, South Africa."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Williamson C"
          ],
          "firstName": [
            "Carolyn"
          ],
          "lastName": [
            "Williamson"
          ],
          "initials": [
            "C"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.",
                "Division of Medical Virology, University of Cape Town, Cape Town, South Africa.",
                "The National Health Laboratory Service, Cape Town, South Africa.",
                "Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Abdool Karim Q"
          ],
          "firstName": [
            "Quarraisha"
          ],
          "lastName": [
            "Abdool Karim"
          ],
          "initials": [
            "Q"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.",
                "Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA."
              ]
            }
          ]
        }
      ]
    }
  ],
  "authorIdList": [
    {
      "authorId": [
        {
          "_": "0000-0002-7607-348X",
          "$": {
            "type": "ORCID"
          }
        }
      ]
    }
  ],
  "dataLinksTagsList": [
    {
      "dataLinkstag": [
        "altmetrics"
      ]
    }
  ],
  "journalInfo": [
    {
      "issue": [
        "1"
      ],
      "volume": [
        "20"
      ],
      "journalIssueId": [
        "2973514"
      ],
      "dateOfPublication": [
        "2020 Jul"
      ],
      "monthOfPublication": [
        "7"
      ],
      "yearOfPublication": [
        "2020"
      ],
      "printPublicationDate": [
        "2020-07-01"
      ],
      "journal": [
        {
          "title": [
            "BMC infectious diseases"
          ],
          "ISOAbbreviation": [
            "BMC Infect. Dis."
          ],
          "medlineAbbreviation": [
            "BMC Infect Dis"
          ],
          "NLMid": [
            "100968551"
          ],
          "ISSN": [
            "1471-2334"
          ],
          "ESSN": [
            "1471-2334"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2020"
  ],
  "pageInfo": [
    "532"
  ],
  "abstractText": [
    "BACKGROUND:The World Health Organisation recommends the use of tenofovir-containing pre-exposure prophylaxis (PrEP) as an additional Human Immunodeficiency Virus (HIV) prevention choice for men and women at substantial risk of HIV infection. PrEP could fill an important HIV prevention gap, especially for sexually active young women who are limited in their ability to negotiate mutual monogamy or condom use. As PrEP is scaled up in high HIV incidence settings, it is crucial to consider the importance of early identification of HIV infection during PrEP use, to allow for rapid discontinuation of PrEP to reduce the risk of antiretroviral (ARV) resistance. The purpose of this case study is to provide this critical evidence. CASE PRESENTATION:This report describes a 20-year-old woman in a HIV sero-discordant relationship who initiated oral PrEP (tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC)) through a demonstration project (CAPRISA 084) in October 2017. Despite good adherence throughout her PrEP use, she tested HIV antibody positive at month nine of study participation. Retrospective testing showed increasing HIV viral load over time, and retrospective use of fourth-generation rapid HIV tests showed HIV detection (positive antigen/antibody) at month one. Sequencing confirmed a dominant wild type at month one with dual therapy resistance patterns emerging by month three (M184V and K65R mutations), which is suggestive of protracted PrEP use during an undetected HIV infection. The participant was referred to infectious diseases for further management of her HIV infection and was initiated on a first line, tenofovir-sparing regimen. At the time of this report (January 2020), the participant had been on ARV- therapy (ART) for 13 months and had no signs of either clinical, immunologic or virologic failure. CONCLUSIONS:This case report highlights the importance of appropriate HIV screening during wider oral PrEP scale-up in high HIV incidence settings to circumvent the consequences of prolonged dual therapy in an undiagnosed HIV infection and in turn prevent ARV resistance."
  ],
  "affiliation": [
    "Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa."
  ],
  "publicationStatus": [
    "epublish"
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Electronic"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "Journal Article",
        "Case Reports",
        "case-report"
      ]
    }
  ],
  "grantsList": [
    {
      "grant": [
        {
          "grantId": [
            "AID-674-A-14-00009"
          ],
          "agency": [
            "FHI 360"
          ],
          "orderIn": [
            "0"
          ]
        },
        {
          "grantId": [
            "UID: 96354"
          ],
          "agency": [
            "Department of Science and Technology, Republic of South Africa"
          ],
          "orderIn": [
            "0"
          ]
        }
      ]
    }
  ],
  "meshHeadingList": [
    {
      "meshHeading": [
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Humans"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "HIV-1"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "GE"
                  ],
                  "qualifierName": [
                    "genetics"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "IM"
                  ],
                  "qualifierName": [
                    "immunology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "HIV Seropositivity"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Benzoxazines"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "TU"
                  ],
                  "qualifierName": [
                    "therapeutic use"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Lamivudine"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "TU"
                  ],
                  "qualifierName": [
                    "therapeutic use"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Zidovudine"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "TU"
                  ],
                  "qualifierName": [
                    "therapeutic use"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Drug Combinations"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Anti-HIV Agents"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "TU"
                  ],
                  "qualifierName": [
                    "therapeutic use"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Treatment Outcome"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Viral Load"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DE"
                  ],
                  "qualifierName": [
                    "drug effects"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Administration, Oral"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Retrospective Studies"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Drug Resistance, Viral"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DE"
                  ],
                  "qualifierName": [
                    "drug effects"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "GE"
                  ],
                  "qualifierName": [
                    "genetics"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "South Africa"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Female"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Young Adult"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Epidemics"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "PC"
                  ],
                  "qualifierName": [
                    "prevention & control"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Pre-Exposure Prophylaxis"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "MT"
                  ],
                  "qualifierName": [
                    "methods"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "AD"
                  ],
                  "qualifierName": [
                    "administration & dosage"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "AE"
                  ],
                  "qualifierName": [
                    "adverse effects"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "TU"
                  ],
                  "qualifierName": [
                    "therapeutic use"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        }
      ]
    }
  ],
  "keywordList": [
    {
      "keyword": [
        "Hiv Prevention",
        "Tenofovir",
        "Hiv Drug Resistance",
        "Pre-exposure Prophylaxis (Prep)",
        "Fourth-generation Rapid Tests For Hiv Screening",
        "Prep Breakthrough Infections In Hiv-endemic Settings"
      ]
    }
  ],
  "chemicalList": [
    {
      "chemical": [
        {
          "name": [
            "Drug Combinations"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Anti-HIV Agents"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Benzoxazines"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "lamivudine, zidovudine drug combination"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Lamivudine"
          ],
          "registryNumber": [
            "2T8Q726O95"
          ]
        },
        {
          "name": [
            "Zidovudine"
          ],
          "registryNumber": [
            "4B9XT59T7S"
          ]
        },
        {
          "name": [
            "efavirenz"
          ],
          "registryNumber": [
            "JE6H2O27P8"
          ]
        },
        {
          "name": [
            "Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination"
          ],
          "registryNumber": [
            "0"
          ]
        }
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.1186/s12879-020-05255-5"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7374822"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7374822?pdf=render"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "N"
  ],
  "citedByCount": [
    "0"
  ],
  "hasData": [
    "N"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "license": [
    "cc by"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "N"
  ],
  "dateOfCompletion": [
    "2020-08-28"
  ],
  "dateOfCreation": [
    "2020-07-24"
  ],
  "firstIndexDate": [
    "2020-07-24"
  ],
  "fullTextReceivedDate": [
    "2020-07-28"
  ],
  "dateOfRevision": [
    "2020-08-28"
  ],
  "electronicPublicationDate": [
    "2020-07-22"
  ],
  "firstPublicationDate": [
    "2020-07-22"
  ]
}